Efficacy of switching to dolutegravir plus rilpivirine, the small-tablet regimen, in patients with dysphagia: two case reports

BACKGROUND: The advent of well-tolerated and effective anti-retroviral drugs against human immunodeficiency virus-1 (HIV-1) infection has been a major step forward that has achieved long-term survival in recent years. The number of HIV-1 infected patients who experience difficulty in swallowing tabl...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Pharm Health Care Sci
Autores principales: Suzuki, Takefumi, Hara, Nobuko, Osa, Morichika, Misawa, Kazuhisa, Imai, Kazuo, Fujikura, Yuji, Maeda, Takuya, Sonehara, Wataru, Kawana, Akihiko
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5606108/
https://ncbi.nlm.nih.gov/pubmed/28944075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40780-017-0093-8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares